08
2016-01On December 30, 2015, the Journal of Virology published an advanced research work, entitled “Human mucosal mast cells capture HIV-1 and mediate viral trans-infection of CD4+ T cells”, from Jian-Hua WANG`s Lab, Institute Pasteur of Shanghai, Chinese Academy of Sciences. This work reveals a novel...On December 30, 2015, the Journal of Virology published an advanced research work, entitled “Human mucosal mast cells capture HIV-1 and mediate viral trans-infection of CD4+ T cells”, from Jian-Hua WANG`s Lab, Institute Pasteur of Shanghai, Chinese Academy of Sciences. This work reveals a novel...
08
2016-01On January 6th, 2016,the Journal of Biological Chemistry published an advanced research work, entitled “HIV-1 Nef-associated factor 1 enhances viral production by interacting with CRM1 to promote nuclear export of unspliced HIV-1 gag mRNA”, from Jian-Hua WANG`s Lab, Institute Pasteur of Shang...On January 6th, 2016,Journal of Biological Chemistry published an advanced research work, entitled “HIV-1 Nef-associated factor 1 enhances viral production by interacting with CRM1 to promote nuclear export of unspliced HIV-1 gag mRNA”, from Jian-Hua WANG`s Lab, Institute Pasteur of Shanghai,...
11
2015-11Kaposi’s sarcoma-associated herpesvirus (KSHV), known as human herpesvirus 8 (HHV8), is the etiological agent of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castelman’s disease (MCD). KSHV has developed a unique mechanism to subvert host antiviral immune responses b...Kaposi’s sarcoma-associated herpesvirus (KSHV), known as human herpesvirus 8 (HHV8), is the etiological agent of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and multicentric Castelman’s disease (MCD). KSHV has developed a unique mechanism to subvert host antiviral immune responses b...
29
2015-10On October 15th, the international clinical research journal Journal of Infectious Diseases (JID) published the Phase I clinical trial of candidate HIV vaccines entitled " Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conser...On October 15th, the international clinical research journal Journal of Infectious Diseases (JID) published the Phase I clinical trial of candidate HIV vaccines entitled " Vaccination with heterologous HIV envelope sequences and heterologous adenovirus vectors increases T cell responses to conser...